Prevalence of Asthma and Allergies among children in UAE

Trial Identifier: D2287R00142
Sponsor: AstraZeneca
NCTID:: NCT03878680
Start Date: April 2019
Primary Completion Date: June 2019
Study Completion Date: June 2019
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United Arab Emirates Ajman, United Arab Emirates
United Arab Emirates Dubai, United Arab Emirates
United Arab Emirates FUJ, United Arab Emirates
United Arab Emirates RAK, United Arab Emirates
United Arab Emirates Sharjah, United Arab Emirates
United Arab Emirates UMQ, United Arab Emirates